Lataa...
Cost per patient of treatment for rifampicin‐resistant tuberculosis in a community‐based programme in Khayelitsha, South Africa
OBJECTIVES: The high cost of rifampicin‐resistant tuberculosis (RR‐TB) treatment hinders treatment access. South Africa has a high RR‐TB burden, and national policy outlines decentralisation to improve access and reduce costs. We analysed health system costs associated with RR‐TB treatment by drug r...
Tallennettuna:
| Julkaisussa: | Trop Med Int Health |
|---|---|
| Päätekijät: | , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
John Wiley and Sons Inc.
2015
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4864411/ https://ncbi.nlm.nih.gov/pubmed/25975868 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/tmi.12544 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|